The Short-term Impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on Respiratory Function in Patients With Lung Cancer

NCT ID: NCT06172959

Last Updated: 2024-09-19

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 1 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-02-21
• Study Completion Date: 2024-06-01

Brief Summary

The purpose of this study is to examine the short-term impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on respiratory function in patients with lung cancer. As a secondary outcome, this research will evaluate the effect of the music intervention on respiratory quality of life.

Conditions

Lung Cancer

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: NONE

Study Groups

Vocal Therapy Group

Participants in this group will receive Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) for up to three weeks

Group Type: EXPERIMENTAL

Vocal Intonation Therapy (VIT)

Intervention Type: BEHAVIORAL

Participants will receive 12 individual sessions, four times a week (i.e., any four days of seven days) over three weeks. Each session will be held virtually for 30-minutes. Vocal Intonation Therapy is a music therapy technique consisting of breathing and vocal exercises to target respiratory function and vocal quality.

Therapeutic Singing (TS)

Intervention Type: BEHAVIORAL

Participants will receive 12 individual sessions, four times a week (i.e., any four days of seven days) over three weeks. Each session will be held virtually for 30-minutes. Therapeutic Singing is a music therapy technique used to work on the rehabilitation of vocal and respiratory function.

Interventions

Vocal Intonation Therapy (VIT)

Participants will receive 12 individual sessions, four times a week (i.e., any four days of seven days) over three weeks. Each session will be held virtually for 30-minutes. Vocal Intonation Therapy is a music therapy technique consisting of breathing and vocal exercises to target respiratory function and vocal quality.

Intervention Type: BEHAVIORAL

Therapeutic Singing (TS)

Participants will receive 12 individual sessions, four times a week (i.e., any four days of seven days) over three weeks. Each session will be held virtually for 30-minutes. Therapeutic Singing is a music therapy technique used to work on the rehabilitation of vocal and respiratory function.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Participants will include three patients diagnosed with lung cancer, stages I-III, who have undergone a thoracentesis or thoracotomy in the last 12 months. Thoracic surgical procedures include pulmonary lobectomy or cancer-related surgical procedure (e.g., pneumonectomy). This diagnosis must be made by the patient's oncologist and medical team.
• The age range will be 40 to 80 years old. Both female and male participants from any race and ethnicity will be included in the study.
• The study will include English and Spanish speakers only.
• Patients must have less than five years of voice training experience (e.g., choir, private voice lessons).

Exclusion Criteria

• Patients in respiratory failure
• Individuals with severe neurological and hearing impairments.
• Patients with diagnosed dysphonia and individuals who have undergone a laryngectomy
• Participants that do not have access to an electronic device, either an iPad, tablet, or laptop, as well as reliable internet access. They will also need to have adequate knowledge of technology or participate with a caregiver who knows how to navigate Zoom.
• Participants who do not have access to a quiet space. Headphones are optional for this study.
• Prisoners
• Persons under the age of 40 or over the age of 80.

• Minimum Eligible Age: 40 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University of Miami

OTHER

Sponsor Role: lead

Responsible Party

Teresa Lesiuk

Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Teresa Lesiuk, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Miami

Locations

University of Miami

Coral Gables, Florida, United States

Countries

United States

Other Identifiers

20230944

Identifier Type: -

Identifier Source: org_study_id